159 related articles for article (PubMed ID: 17982702)
1. Phospholipase A as a potent virulence factor of Vibrio vulnificus.
Koo BS; Lee JH; Kim SC; Yoon HY; Kim KA; Kwon KB; Kim HR; Park JW; Park BH
Int J Mol Med; 2007 Dec; 20(6):913-8. PubMed ID: 17982702
[TBL] [Abstract][Full Text] [Related]
2. A conserved GTPase YchF of Vibrio vulnificus is involved in macrophage cytotoxicity, iron acquisition, and mouse virulence.
Chen YC; Chung YT
Int J Med Microbiol; 2011 Aug; 301(6):469-74. PubMed ID: 21570909
[TBL] [Abstract][Full Text] [Related]
3. Identification and characterization of
Jang KK; Lee ZW; Kim B; Jung YH; Han HJ; Kim MH; Kim BS; Choi SH
J Biol Chem; 2017 Oct; 292(41):17129-17143. PubMed ID: 28855258
[TBL] [Abstract][Full Text] [Related]
4. Low-density lipoprotein protects Vibrio vulnificus-induced lethality through blocking lipopolysaccharide action.
Park KH; Kim JS; Lee YR; Moon YJ; Hur H; Choi YH; Kim CH; Kim UH; Song EK; Yoo WH; Lee CS; Kim BS; Lee SH; Ryu PY; Han MK
Exp Mol Med; 2007 Oct; 39(5):673-8. PubMed ID: 18059143
[TBL] [Abstract][Full Text] [Related]
5. Quorum sensing-dependent metalloprotease VvpE is important in the virulence of Vibrio vulnificus to invertebrates.
Ha C; Kim SK; Lee MN; Lee JH
Microb Pathog; 2014; 71-72():8-14. PubMed ID: 24769338
[TBL] [Abstract][Full Text] [Related]
6. The virulence of Vibrio vulnificus is affected by the cellular level of superoxide dismutase activity.
Kang IH; Kim JS; Lee JK
J Microbiol Biotechnol; 2007 Aug; 17(8):1399-402. PubMed ID: 18051612
[TBL] [Abstract][Full Text] [Related]
7. Identification of the Vibrio vulnificus wbpP gene and evaluation of its role in virulence.
Park NY; Lee JH; Kim MW; Jeong HG; Lee BC; Kim TS; Choi SH
Infect Immun; 2006 Jan; 74(1):721-8. PubMed ID: 16369029
[TBL] [Abstract][Full Text] [Related]
8. Safety and vaccine efficacy of an attenuated Vibrio vulnificus strain with deletions in major cytotoxin genes.
Kim YR; Lee SE; Kim JR; Rhee JH
FEMS Microbiol Lett; 2015 Dec; 362(23):fnv169. PubMed ID: 26381905
[TBL] [Abstract][Full Text] [Related]
9. Vibrio vulnificus infection: clinical manifestations, pathogenesis, and antimicrobial therapy.
Chiang SR; Chuang YC
J Microbiol Immunol Infect; 2003 Jun; 36(2):81-8. PubMed ID: 12886957
[TBL] [Abstract][Full Text] [Related]
10. Identification of OmpU of Vibrio vulnificus as a fibronectin-binding protein and its role in bacterial pathogenesis.
Goo SY; Lee HJ; Kim WH; Han KL; Park DK; Lee HJ; Kim SM; Kim KS; Lee KH; Park SJ
Infect Immun; 2006 Oct; 74(10):5586-94. PubMed ID: 16988233
[TBL] [Abstract][Full Text] [Related]
11. A calcium-calmodulin antagonist blocks experimental Vibrio vulnificus cytolysin-induced lethality in an experimental mouse model.
Lee YR; Park KH; Lin ZZ; Kho YJ; Park JW; Rho HW; Koo BS; Kim HR; Song EK; Yu HN; Han MK; Lee SO; Jhee EC; Kim JS
Infect Immun; 2004 Oct; 72(10):6157-9. PubMed ID: 15385523
[TBL] [Abstract][Full Text] [Related]
12. Vibrio vulnificus damages macrophages during the early phase of infection.
Tsuchiya T; Mitsuo E; Hayashi N; Hikita Y; Nakao H; Yamamoto S; Miyamoto K; Tsujibo H
Infect Immun; 2007 Sep; 75(9):4592-6. PubMed ID: 17591793
[TBL] [Abstract][Full Text] [Related]
13. RRSP and RID Effector Domains Dominate the Virulence Impact of Vibrio vulnificus MARTX Toxin.
Gavin HE; Satchell KJF
J Infect Dis; 2019 Feb; 219(6):889-897. PubMed ID: 30289477
[TBL] [Abstract][Full Text] [Related]
14. RTX toxin enhances the survival of Vibrio vulnificus during infection by protecting the organism from phagocytosis.
Lo HR; Lin JH; Chen YH; Chen CL; Shao CP; Lai YC; Hor LI
J Infect Dis; 2011 Jun; 203(12):1866-74. PubMed ID: 21422475
[TBL] [Abstract][Full Text] [Related]
15. Vibrio vulnificus cytolysin induces inflammatory responses in RAW264.7 macrophages through calcium signaling and causes inflammation in vivo.
Qin K; Fu K; Liu J; Wu C; Wang Y; Zhou L
Microb Pathog; 2019 Dec; 137():103789. PubMed ID: 31605759
[TBL] [Abstract][Full Text] [Related]
16. Vibrio vulnificus rtxE is important for virulence, and its expression is induced by exposure to host cells.
Lee BC; Lee JH; Kim MW; Kim BS; Oh MH; Kim KS; Kim TS; Choi SH
Infect Immun; 2008 Apr; 76(4):1509-17. PubMed ID: 18250174
[TBL] [Abstract][Full Text] [Related]
17. High growing ability of Vibrio vulnificus biotype 1 is essential for production of a toxic metalloprotease causing systemic diseases in humans.
Watanabe H; Miyoshi S; Kawase T; Tomochika K; Shinoda S
Microb Pathog; 2004 Mar; 36(3):117-23. PubMed ID: 14726228
[TBL] [Abstract][Full Text] [Related]
18. Genistein inhibits Vibrio vulnificus adhesion and cytotoxicity to HeLa cells.
Oh DR; Kim JR; Kim YR
Arch Pharm Res; 2010 May; 33(5):787-92. PubMed ID: 20512479
[TBL] [Abstract][Full Text] [Related]
19. Use of a marker plasmid to examine differential rates of growth and death between clinical and environmental strains of Vibrio vulnificus in experimentally infected mice.
Starks AM; Bourdage KL; Thiaville PC; Gulig PA
Mol Microbiol; 2006 Jul; 61(2):310-23. PubMed ID: 16856938
[TBL] [Abstract][Full Text] [Related]
20. Outer membrane vesicles of Vibrio vulnificus deliver cytolysin-hemolysin VvhA into epithelial cells to induce cytotoxicity.
Kim YR; Kim BU; Kim SY; Kim CM; Na HS; Koh JT; Choy HE; Rhee JH; Lee SE
Biochem Biophys Res Commun; 2010 Sep; 399(4):607-12. PubMed ID: 20682286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
